Boston Scientific Corp (BSX): Shareholders' Equity
$24.47B
As of 2025-12-31
$25.17B
As of 2026-06-30
+11.7%
3-year compound annual growth
+9.8%
5-year compound annual growth
+14.5%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.47B | +11.2% | 2026-02-17, Balance as of period end |
| 2024-12-31 | $22.00B | +12.7% | 2026-02-17, Balance as of period end |
| 2023-12-31 | $19.53B | +11.1% | 2026-02-17, Balance as of period end |
| 2022-12-31 | $17.57B | +5.7% | 2025-02-18, Balance as of period end |
| 2021-12-31 | $16.62B | +8.5% | 2024-02-20, Balance as of period end |
| 2020-12-31 | $15.33B | +10.4% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $13.88B | +59.0% | 2022-02-23, Balance as of period end |
| 2018-12-31 | $8.73B | +24.4% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $7.01B | +4.1% | 2019-02-19, Balance as of period end |
| 2016-12-31 | $6.73B | +6.5% | 2018-02-20, Balance as of period end |
| 2015-12-31 | $6.32B | -2.1% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $6.46B | -1.3% | 2016-02-24, Balance as of period end |
| 2013-12-31 | $6.54B | -4.8% | 2015-02-25, Balance as of period end |
| 2012-12-31 | $6.87B | -39.5% | 2014-02-26, Balance as of period end |
| 2011-12-31 | $11.35B | +0.5% | 2013-02-22, Balance as of period end |
| 2010-12-31 | $11.30B | -8.2% | 2012-02-17, Balance as of period end |
| 2009-12-31 | $12.30B | -6.6% | 2011-02-17, Balance as of period end |
| 2008-12-31 | $13.17B | n/a | 2011-02-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Boston Scientific Corp (BSX) | 2025-12-31 | $24.47B | +11.2% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $25.39B | -1.9% |
| 3M Co (MMM) | 2025-12-31 | $4.75B | +21.9% |
| Stryker Corp (SYK) | 2025-12-31 | $22.42B | +8.7% |
| Medline Inc. (MDLN) | 2025-12-31 | $10.74B | n/a |
| Baxter International Inc (BAX) | 2025-12-31 | $6.10B | -13.1% |
| Solventum Corp (SOLV) | 2025-12-31 | $5.05B | +70.6% |
| ResMed Inc (RMD) | 2026-06-30 | $6.59B | +10.3% |
| Dexcom Inc (DXCM) | 2025-12-31 | $2.75B | +30.6% |
Compare BSX, BDX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗